Pathogenesis and treatment of myasthenia gravis.
作者信息
Simpson J A
出版信息
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1332-3. doi: 10.1136/bmj.283.6302.1332-d.
Abstract
摘要
相似文献
1
Pathogenesis and treatment of myasthenia gravis.重症肌无力的发病机制与治疗
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1332-3. doi: 10.1136/bmj.283.6302.1332-d.
2
[Myasthenia gravis (3). Corticosteroid therapy of myasthenia gravis].[重症肌无力（3）。重症肌无力的皮质类固醇治疗]
Lakartidningen. 1978 Oct 11;75(41):3667-9.
3
Myasthenia gravis: from autoantibodies to therapy.重症肌无力：从自身抗体到治疗。
Curr Opin Neurol. 2018 Oct;31(5):517-525. doi: 10.1097/WCO.0000000000000596.
4
Exacerbation of myasthenia gravis during imiquimod treatment.咪喹莫特治疗期间重症肌无力病情加重。
J Drugs Dermatol. 2007 Jul;6(7):745-6.
5
[D-penicillamine-induced myasthenia gravis].[青霉胺诱发的重症肌无力]
Schweiz Med Wochenschr. 1994 May 21;124(20):852-6.
6
Overview of myasthenia gravis.重症肌无力概述
Hosp Pract (1995). 2013 Oct-Nov;41(4):40-50. doi: 10.3810/hp.2013.10.1079.
7
[Myasthenia gravis treated with immunosuppressive drugs].[免疫抑制药物治疗重症肌无力]
Orv Hetil. 1969 Dec 21;110(51):2977-80.
8
[Intravenous immunoglobulin in myasthenia gravis].[静脉注射免疫球蛋白治疗重症肌无力]
Nihon Rinsho. 2015 Sep;73 Suppl 7:511-4.
9
[Intensified Scandinavian cooperation for better care in myasthenia gravis].[加强斯堪的纳维亚地区合作以改善重症肌无力的护理]
Lakartidningen. 1992 Oct 7;89(41):3367-8.
10
Autoimmune mechanisms in myasthenia gravis.重症肌无力的自身免疫机制。
Curr Opin Neurol. 2012 Oct;25(5):621-9. doi: 10.1097/WCO.0b013e328357a829.
本文引用的文献
1
Pathogenesis and treatment of myasthenia gravis.重症肌无力的发病机制与治疗
Br Med J (Clin Res Ed). 1981 Oct 17;283(6298):1008-12. doi: 10.1136/bmj.283.6298.1008.
Zotero 插件